Navigation Links
Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting

-- Data from Picoplatin Phase 1 Colorectal and Prostate Cancer Trials To Be Published in 2007 ASCO Proceedings --

SOUTH SAN FRANCISCO, Calif., May 23, 2007 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. , a biopharmaceutical company focused on oncology, today announced that data from a Phase 2 trial of picoplatin, the Company's lead product candidate, in patients with small cell lung cancer (SCLC) will be presented in a poster session at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) at McCormick Place in Chicago. Details are as follows:

    -- Abstract #7722, Poster #EE3

       A Phase 2 study of picoplatin as second-line therapy for patients with

       small cell lung cancer who have resistant or refractory disease or have

       relapsed within 180 days of completing first-line, platinum-containing

       chemotherapy.

       Bentzion D, Lipatov O, Poliakov I, MacKintosh R, Eckardt J, Breitz H.

       General Poster Session: Sunday, June 3, 8:00 a.m. to 12 p.m. Central

       time S Hall A2

In addition, two picoplatin abstracts have been selected for publication in the 2007 ASCO Proceedings and will be available online through http://asco.org. These abstracts include safety data from an ongoing Phase 1/2 study of picoplatin for the potential front-line treatment of colorectal cancer and from an ongoing Phase 1/2 study of picoplatin and docetaxel (Taxotere(R)) in chemotherapy-naive patients with metastatic hormone-refractory prostate cancer. Details are as follows:

    -- Abstract #14510

       Phase 1 study of picoplatin in combination with 5-fluorouracil and

       leucovorin as initial therapy in subjects with metastatic colorectal

       cancer.

       Gladkov Jr O, Manikhas G, Biakhov M, Tjulandin S, Karlin D.


    -- Abstract #15546

       Phase 1 study of picoplatin and doc
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:9/19/2014)... WEST CHESTER, Pa. , Sept. 19, 2014 ... Johnson launched two new variable angle plating systems ... this technology, surgeons can adapt screw trajectory to ... screws towards specific fragments of bone. The systems ... Orthopaedic Foot & Ankle Society (AOFAS) and the ...
(Date:9/19/2014)... VIEW, Calif. , Sept. 19, 2014 Today, ... in capital from Xiaomi Ventures, Ltd. for its first ... used to continue expanding iHealth,s global reach, accelerate growth ... resources.  As part of the investment, Xiaomi Ventures will ... the areas of cloud infrastructure and ecommerce. ...
(Date:9/19/2014)... 2014  The board of directors of AbbVie Inc. ... dividend of $0.42 per share.  The ... of record at the close of business on Oct. ... global, research-based biopharmaceutical company formed in 2013 following separation ... expertise, dedicated people and unique approach to innovation to ...
Breaking Medicine Technology:DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 2DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 3iHealth Raises $25 Million to Fuel Growth and Global Market Share 2
(Date:9/21/2014)... Mills, Md. (PRWEB) September 21, 2014 Faculty ... school with a coed preschool in Owings Mills, Md., kicked ... wellness with Garmin Vivofit bands. GFS is the first independent ... steps taken, calories burned and even sleep patterns— as part ... a Baltimore area running and walking specialty chain. The Vivofit ...
(Date:9/21/2014)... Top10BestSEOHosting.com, a leading review website, has ... are the most recommended hosting suppliers for the ... hosting products. , “Don’t waste your time ... two great hosting companies to you,” the IT ... and GreenGeeks are the most recommended suppliers for ...
(Date:9/20/2014)... (PRWEB) September 21, 2014 Diabetes ... Kenneth Pullman that is helping thousands of people learn ... symptoms without shots, pills, or prescriptions has caught the ... , “There are currently tens of millions of people ... 1 and Type 2 diabetes, and unfortunately, big pharma ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 David Cooke ... 2014. The first poster looked at the clinical benefits ... cycle for calculating diastolic function. In conjunction with colleagues ... renal disease and normal LVEF by echo (>50%). Each ... protocol, and standard SPECT. Emory Toolbox 4.0 ...
(Date:9/20/2014)... Increases in household, construction and ... treatment volumes. However, government regulations and higher landfill ... According to IBISWorld industry analyst Alen Allday, “over ... at reducing the volume of waste generated, and ... Still, a large proportion of waste generated by ...
Breaking Medicine News(10 mins):Health News:Garrison Forest School Leader in Independent School Wellness Programs 2Health News:Leading Review Website Top10BestSEOHosting.com Unveils The Best Hosting Suppliers In September 2Health News:Diabetes Protocol: Review Exposes Kenneth Pullman’s Breakthrough Discovery About Diabetes Management 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3
... A study released today in the Annals ... lower death rates from colorectal cancer, however, the procedure missed ... versus the left side. The study highlights the importance ... colonoscopy and that patients must take the bowel prep as ...
... people, mainly in developing countries, are disabled by infectious ... More than 12 million people in 88 countries are ... bite of infected sand flies. Nearly 2 million new ... the disease annually. , Researchers at the University ...
... improve use of treatments proven to cut post-illness complications ... hospitals enrolled in a voluntary program to improve stroke ... to a five-year study that included 790 hospitals that ... to 2007. , The hospitals, which signed on to ...
... that they know. Or maybe not. A new study published in Human ... human genome must pay attention to ancestry when analyzing and interpreting their ... ... someone where their ancestors were from and odds are that they know. ...
... 2008 -- Structural interventions and public safety messages may ... and improve the overall safety of New York City ... Columbia University,s Mailman School of Public Health. Subway safety ... relatively safe mode of transportation, it has the highest ...
... Dec. 16 Judges and doctors with extensive,experience on the ... at the "Emerging Trends in Asbestos Litigation" to be held ... 9-11, 2009. , The ... Judges include the Hon. Sandra ...
Cached Medicine News:Health News:ASGE urges patients to seek a qualified endoscopist before undergoing a colonoscopy 2Health News:ASGE urges patients to seek a qualified endoscopist before undergoing a colonoscopy 3Health News:UIC researchers hunting drugs for devastating parasitic disease 2Health News:Program Aids Hospital Compliance With Stroke Guidelines 2Health News:Genome-wide Association Studies Must Account for Ancestry 2Health News:Genome-wide Association Studies Must Account for Ancestry 3Health News:'Don't drink and ride': Improving subway safety 2Health News:Judges, Doctors Featured at Mealey's Asbestos Conference in March 2
Rotating 360 degrees, 3 mm x 7 mm bite....
45 degree, forward 3 mm, 4 mm x 5 mm cup, length of shaft 140 mm, overall length 8.3 inches....
20 mm. Plastic, methylmethacrylate. Supplied sterile....
Small right. Teflon orbital plates....
Medicine Products: